"It's my secret": barriers to paediatric HIV treatment in a poor rural South African setting

E W Kimani-Murage1, L Manderson, S A Norris

  • 1African Population and Health Research Center, Nairobi, Kenya. lizmurage@gmail.com

AIDS Care
|December 19, 2012
PubMed

Insights

Barriers to pediatric HIV care in rural South Africa include stigma, misconceptions, and poor healthcare access. Addressing these requires community interventions and improved healthcare professional training to increase anti-retroviral therapy coverage.

Area of Science:

  • Public Health
  • Pediatric HIV/AIDS
  • Qualitative Research

Background:

  • A significant proportion of children in South Africa are born exposed to HIV, with low rates of confirmatory testing and anti-retroviral therapy (ART) coverage.
  • The national ART program in South Africa, initiated in 2004, has not achieved adequate ART coverage among children.

Purpose of the Study:

  • To investigate critical barriers preventing children in rural South Africa from accessing HIV-related care.
  • To understand the factors influencing delayed treatment-seeking for pediatric HIV.

Main Methods:

  • Community-based qualitative research conducted in poor rural villages in north-east South Africa.
  • 21 in-depth interviews with caregivers of HIV-positive children (identified in 2007) were conducted in 2008.
  • Data analysis employed NVIVO 8 and a constant comparative method to identify themes.

Main Results:

  • Structural, social, and systemic barriers significantly impede access to pediatric HIV care.
  • Caregivers' need for secrecy due to stigma and discrimination, coupled with misconceptions about childhood HIV, leads to delayed care-seeking.
  • Poor access to healthcare and rural poverty were identified as contributing factors.

Conclusions:

  • Addressing pediatric HIV care barriers requires multifaceted interventions, including awareness campaigns, improved healthcare access, and socioeconomic development initiatives.
  • Enhanced training for healthcare professionals is recommended to improve attitudes and practices towards pediatric HIV care.
  • Further research involving healthcare providers is necessary to complement caregiver perspectives for comprehensive policy and practice guidance.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...